Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

FDA Answers Common Questions about Tamiflu
The FDA has published a web page titled "Tamiflu: Consumer Questions and Answers." Tamiflu (oseltamivir) is an antiviral drug. It works by attacking the flu virus to keep it from multiplying in your body and by reducing the symptoms of the flu. Tamiflu is typically used to treat patients who have had flu symptoms for less than 2 days. If you are exposed to someone with the flu, Tamiflu can sometimes keep you from getting the flu, but only if you take it before you get sick. To view the FDA's web page about Tamiflu, please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm188859.htm For more information on all available influenza (flu) antiviral drugs and other related information, please visit: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm100228.htm
Learn More

Reports of Altered Kidney Function in Patients Using Byetta
The FDA has approved revisions to the prescribing information for Byetta (exenatide) to include information about post-marketing reports of decreased kidney function, including cases of acute renal failure where the kidneys suddenly stop working. Some of the cases have been associated with dehydration from nausea, vomiting, and diarrhea, which are known side effects of Byetta. These reported cases of altered kidney function have occurred in a very small percentage of the total number of patients who have used Byetta. Byetta is a medicine given by subcutaneous injection for the treatment of Type 2 Diabetes. For more information please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm188656.htm
Learn More

Date Published Title Drug Source
2009-11-04 FDA Answers Common Questions about Tamiflu Oseltamivir FDA
2009-11-03 Reports of Altered Kidney Function in Patients Using Byetta Exenatide FDA
2009-10-29 Newer Antipsychotics Associated with Significant Weight Gain With Short-Term Use in Children and Adolescents Risperidone MediGuard CRT
2009-10-29 Newer Antipsychotics Associated with Significant Weight Gain With Short-Term Use in Children and Adolescents Quetiapine MediGuard CRT
2009-10-28 Newer Antipsychotics Associated with Significant Weight Gain With Short-Term Use in Children and Adolescents Olanzapine MediGuard CRT
2009-10-28 Newer Antipsychotics Associated with Significant Weight Gain With Short-Term Use in Children and Adolescents Aripiprazole MediGuard CRT
2009-10-28 Recall of All Accusure Insulin Syringes Insulin Glargine FDA
2009-10-28 Recall of All Accusure Insulin Syringes Insulin Lispro FDA
2009-10-28 Recall of All Accusure Insulin Syringes Insulin Aspart FDA
2009-10-28 Recall of All Accusure Insulin Syringes Insulin Manufacturer
2009-10-26 Update on Risk of Progressive Multifocal Leukoencephalopathy (PML) with Use of Rituxan Rituximab FDA
2009-10-25 Recall of Several Lots of Teva / Ivax Atenolol 25 mg and 50 mg Tablets Atenolol FDA
2009-10-25 Recall of a Single Lot of Actavis / Catalent Bupropion Extended-Release Tablets 150 mg Bupropion FDA
2009-10-23 Recall of Two Lots of Cytomel 25 mcg (Liothyronine) Tablets Liothyronine FDA
2009-10-23 Recall of Several Acetaminophen Products Acetaminophen FDA
2009-10-18 Recall of Single Lot of Advair Diskus 100/50mcg Fluticasone Propionate with Salmeterol FDA
2009-10-18 Three Lots of Lac-Hydrin Recalled Ammonium Lactate FDA
2009-10-18 Single Lot of Naproxen 500 mg Tablets Recalled Naproxen FDA
2009-10-14 FDA Warns Companies to Stop Making Unapproved Codeine Sulfate Tablets Codeine FDA
2009-09-30 Recall of Single Lot of Dr. Reddy's Citalopram 40 mg Tablets Citalopram Manufacturer